A Neuropathology Case Report of a Woman with Down Syndrome who Remained Cognitively Stable
Liou, J.-J.; Lou, J.; Nakagiri, J.; Yong, W.; Hom, C. L.; Doran, E. W.; Totoiu, M.; Lott, I.; Mapstone, M.; Keator, D. B.; Brickman, A. M.; Wright, S.; Nelson, B.; Lai, F.; Xicota, L.; Dang, L.-H. T.; Li, J.; Santini, T.; Mettenburg, J. M.; Ikonomovic, M. D.; Kofler, J.; Ibrahim, T.; Head, E.
Show abstract
In this neuropathology case report, we present findings from an individual with Down syndrome (DS) who remained cognitively stable despite Alzheimers disease (AD) neuropathology. Clinical assessments, fluid biomarkers, neuroimaging, and neuropathological examinations were conducted to characterize her condition. Notably, her ApoE genotype was E2/3, which is associated with a decreased risk of dementia. Neuroimaging revealed stable yet elevated amyloid profiles and moderately elevated tau levels, while neuropathology indicated intermediate AD neuropathologic change with Lewy body pathology and cerebrovascular pathology. Despite the presence of AD pathology, the participant demonstrated intact cognitive functioning, potentially attributed to factors such as genetic variations, cognitive resilience, and environmental enrichment. The findings suggest a dissociation between clinical symptoms and neuropathological changes, emphasizing the complexity of AD progression in DS. Further investigation into factors influencing cognitive resilience in individuals with DS, including comorbidities and social functioning, is warranted. Understanding the mechanisms underlying cognitive stability in DS could offer insights into resilience to AD neuropathology in people with DS and in the general population and inform future interventions.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Brain Amyloid and the Transition to Dementia in Down Syndrome 97%
- Association of Item-Level Responses to Cognitive Function Index with Tau Pathology and Hippocampal volume in The A4 Study 97%
- Delayed primacy recall performance predicts post mortem Alzheimers disease pathology from unimpaired ante mortem cognitive baseline 96%
Similar papers in this journal
- Plasma biomarkers identify brain ATN abnormalities in a dementia-free population-based cohort 97%
- White matter integrity is associated with cognition and amyloid burden in older adult Koreans along the Alzheimer’s disease continuum 97%
- Plasma biomarker profiles and the correlation with cognitive function across the clinical spectrum of Alzheimer’s disease 97%
Similar papers in this journal
- APOE-ε 4 and BIN1 increase risk of Alzheimer’s disease pathology but not specifically of Lewy body pathology 95%
- Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19 95%
- Protein farnesylation is upregulated in Alzheimer's human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer's model mice 94%
Similar papers in this journal
- Alzheimer Disease Neuropathological Comorbidities Are Common in the Younger-Old 97%
- Differences between plasma and CSF p-tau181 and p-tau231 in early Alzheimer’s disease 96%
- The Association of Alzheimer’s Disease-related Blood-based Biomarkers with Cognitive Screening Test Performance in the Congolese Population in Kinshasa 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.